Tela Bio Inc (TELA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,841 | -28,633 | -18,261 | -5,661 | -46,664 |
| Depreciation Amortization | 1,012 | 746 | 483 | 234 | 808 |
| Income taxes - deferred | -144 | 0 | N/A | N/A | N/A |
| Accounts receivable | -762 | -1,745 | 263 | -234 | -3,058 |
| Accounts payable and accrued liabilities | 482 | 636 | 594 | 1,515 | 11 |
| Other Working Capital | -2,013 | -2,325 | -2,217 | -2,630 | -620 |
| Other Operating Activity | -2,329 | -2,743 | -5,943 | -7,608 | 8,666 |
| Operating Cash Flow | $-41,595 | $-34,064 | $-25,081 | $-14,384 | $-40,857 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -989 | -725 | -603 | -304 | -599 |
| Net Acquisitions | 5,440 | 5,366 | 5,366 | 5,000 | N/A |
| Investing Cash Flow | $4,451 | $4,641 | $4,763 | $4,696 | $-599 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 43,426 | 507 | 390 | 384 | 46,556 |
| Other Financing Activity | -369 | -358 | -339 | -328 | -289 |
| Financing Cash Flow | $43,057 | $149 | $51 | $56 | $46,267 |
| Exchange Rate Effect | 28 | -154 | 34 | 46 | 164 |
| Beginning Cash Position | 46,994 | 46,994 | 46,994 | 46,994 | 42,019 |
| End Cash Position | 52,935 | 17,566 | 26,761 | 37,408 | 46,994 |
| Net Cash Flow | $5,941 | $-29,428 | $-20,233 | $-9,586 | $4,975 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,595 | -34,064 | -25,081 | -14,384 | -40,857 |
| Capital Expenditure | -989 | -725 | -603 | -304 | -611 |
| Free Cash Flow | -42,584 | -34,789 | -25,684 | -14,688 | -41,468 |